To summarize the clinical characteristics of children with SLC35A2 gene variants related congenital disorders of glycosylation (SLC35A2-CDG), so as to improve the clinicians' understanding of this disease. Clinical data and gene detection results of 6 epilepsy children with SLC35A2 gene variants were treated in the Department of Pediatrics Peking University First Hospital from April 2019 to February 2020 were analyzed retrospectively. Six children with SLC35A2 gene variants were identified, including 1 male and 5 females. The onset age of seizure was 5.5 (ranged from 2 to 20) months. All 6 cases had epileptic spasms, 2 cases had focal seizures, 2 cases had myoclonic seizures, 1 case had tonic seizures and 1 case had generalized tonic-clonic seizures. All patients with SLC35A2 gene variants were diagnosed as infantile spasm with developmental delay. Four cases had microcephaly, 4 cases had micro skeletal abnormalities, 3 cases had hypotonia and facial dysmorphism, 2 cases had inverted nipples. Visual abnormality, auditory anomaly, congenital cardiac disease and feeding difficulty were observed in one patient. The electroencephalography showed hypsarrhythmia in 6 patients. The brain magnetic resonance imaging (MRI) showed thinning of corpus callosum in 3 patients, delayed myelination in 2 patients and normal brain MRI in 3 patients. There were 2 cases of in-frame deletions, 1 case of missense variant, 1 case of splice site variant, 1 case of 2.14 kb deletion in Xp11.23 (only containing SLC35A2 gene) and 1 case of SLC35A2 gene mosaicism. All 6 cases had de novo variants. The last follow-up age ranged from 18 to 52 months. One patient was seizure free and 5 patients still had frequent seizures after treatment with antiepileptic drugs. SLC35A2 gene variants are mainly de novo variants. The characteristics of patients with SLC35A2-CDG are seizures and developmental delay, infantile spasms are most common diagnosis, micro skeletal anomaly, microcephaly, hypotonia, facial dysmorphism were accompanied features.

Download full-text PDF

Source
http://dx.doi.org/10.3760/cma.j.cn112140-20200308-00198DOI Listing

Publication Analysis

Top Keywords

slc35a2 gene
32
gene variants
24
children slc35a2
12
gene
9
cases
9
slc35a2
8
variants
8
variants congenital
8
congenital disorders
8
disorders glycosylation
8

Similar Publications

ILAE genetic literacy series: Focal cortical dysplasia.

Epileptic Disord

December 2024

Department of Neurology, The Royal Children's Hospital, Parkville, Victoria, Australia.

Focal cortical dysplasia (FCD) is a common cause of drug-resistant focal epilepsy in children and young adults and is often surgically remediable. The genetics of FCD are increasingly understood due to the ability to perform genomic testing including deep sequencing of resected FCD tissue specimens. There is clear evidence that FCD type II occurs secondary to both germline and somatic mTOR pathway variants, while emerging literature supports the role of SLC35A2, a glycosylation gene, in mild malformation of cortical development with oligodendroglial hyperplasia and epilepsy (MOGHE).

View Article and Find Full Text PDF

Lesional focal epilepsy (LFE) is a common and severe seizure disorder caused by epileptogenic lesions, including malformations of cortical development (MCD) and low-grade epilepsy-associated tumors (LEAT). Understanding the genetic etiology of these lesions can inform medical and surgical treatment. We conducted a somatic variant enrichment mega-analysis in brain tissue from 1386 individuals who underwent epilepsy surgery, including 599 previously unpublished individuals with ultra-deep ( > 1600x) targeted panel sequencing.

View Article and Find Full Text PDF
Article Synopsis
  • * A pathogenic variant was found in 31% of the total cases analyzed, with higher rates in specific conditions like focal cortical dysplasia type II (33%) and hemimegalencephaly (62%), particularly involving the mTOR signaling pathway.
  • * The identification of germline and somatic variants, especially in focal epilepsy genes, provides insights for future analyses on genetic factors related to surgical outcomes, which could enhance patient counseling and treatment plans.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates DNA methylation patterns of specific solute carrier genes linked to epilepsy in patients with temporal lobe epilepsy (TLE) and healthy controls.
  • Results show that TLE patients have significantly lower DNA methylation rates compared to controls, which may help in developing predictive models for TLE.
  • The findings indicate that reduced methylation could potentially lead to increased gene expression in TLE, but further research is needed to clarify the mechanisms involved.
View Article and Find Full Text PDF

modulates paramyxovirus fusion events during infection.

bioRxiv

August 2024

Department of Molecular Microbiology and Center for Women Infectious Disease Research, Washington University School of Medicine, St. Louis, MO, USA.

Article Synopsis
  • Paramyxoviruses like mumps virus, Newcastle disease virus, and Sendai virus are important pathogens, but not much is known about the host factors that help them infect cells.
  • A study using CRISPR technology discovered that two genes, CST and UGT, are crucial for these viruses to infect cells, as knocking them out results in reduced viral binding.
  • The UGT gene specifically aids in virus-cell fusion during Sendai virus entry and helps form larger syncytia (cell clusters) during mumps virus infection, indicating it plays a role in how these viruses spread between cells.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!